title: [Evaluation of the efficiency and reactogenicity of emulsion-based adjuvant systems in the manufacture of polyclonal enteroviral diagnostic sera].
abstract: Whether various adjuvants might be used in the manufacture of commercial enteroviral diagnostic sera (EDS) was studied. The following adjuvants: Ribi, SAF-1, and TiterMax were compared; vaseline-lanoline emulsion used to prepare EDSs, as well as modified Freund's complete adjuvant served as controls. Chinchilla rabbits were intramuscularly injected enterovirus antigens (enterovirus 70 and ECHO 2) together with the adjuvant emulsions. TiterMax showed the highest efficiency comparable with the activity of Freund's adjuvant. The activities of Ribi, SAF-1, and vaseline-lanoline emulsion were 3-4 times lower. The neutralizing activity of the sera obtained after 2-3 (TiterMax) or 4-5 (Ribi, SAF-1) immunizations was maximal. Further immunizations resulted in a reduction in the titers of neutralizing antibodies. TiterMax and vaseline-lanoline emulsion caused minimal complications at the site of inoculation whereas SAF-1 and Ribi gave rise to severer inflammatory responses.
authors.forename: V G
authors.initials: VG
authors.lastname: Kozlov
authors.forename: E G
authors.initials: EG
authors.lastname: Viktorova
mesh_terms: D000119:Acetylmuramyl-Alanyl-Isoglutamine / Q000009:adverse effects / Q000031:analogs & derivatives / Q000494:pharmacology; D000276:Adjuvants, Immunologic / Q000009:adverse effects / Q000494:pharmacology*; D000818:Animals; D000914:Antibodies, Viral / Q000096:biosynthesis; D000917:Antibody Formation / Q000276:immunology; D000956:Antigens, Viral / Q000276:immunology; D045744:Cell Line, Tumor; D004655:Emulsions / Q000494:pharmacology*; D004770:Enterovirus / Q000276:immunology*; D005620:Freund's Adjuvant / Q000009:adverse effects / Q000494:pharmacology; D007106:Immune Sera / Q000096:biosynthesis*; D007114:Immunization; D011060:Poloxalene / Q000009:adverse effects / Q000494:pharmacology; D011136:Polysorbates / Q000009:adverse effects / Q000494:pharmacology; D011817:Rabbits; D013185:Squalene / Q000009:adverse effects / Q000031:analogs & derivatives / Q000494:pharmacology
chemical_list: D000276:Adjuvants, Immunologic; D000914:Antibodies, Viral; D000956:Antigens, Viral; D004655:Emulsions; D007106:Immune Sera; D011136:Polysorbates; C077975:Syntex adjuvant formulation; C086752:TiterMax; D000119:Acetylmuramyl-Alanyl-Isoglutamine; D013185:Squalene; D011060:Poloxalene; D005620:Freund's Adjuvant